The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer

The androgen receptor splicing variant 7 (ARv7) that lacks the ligand-binding domain is increasingly considered as a key player leading to enzalutamide (Enz) resistance in patients with prostate cancer (PCa). However, the detailed mechanisms of how ARv7 expression is regulated and whether it also ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bianjiang, Sun, Yin, Tang, Min, Liang, Chao, Huang, Chi-Ping, Niu, Yuanjie, Wang, Zengjun, Chang, Chawnshang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519644/
https://www.ncbi.nlm.nih.gov/pubmed/32978369
http://dx.doi.org/10.1038/s41419-020-02932-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519644/
https://www.ncbi.nlm.nih.gov/pubmed/32978369
http://dx.doi.org/10.1038/s41419-020-02932-w

Ejemplares similares